Clinical Trials Directory

Trials / Completed

CompletedNCT01825005

Predicting Outcome in Cervix Carcinoma: a Prospective Study

Status
Completed
Phase
Study type
Observational
Enrollment
423 (actual)
Sponsor
Maastricht Radiation Oncology · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The main aim is to validate and improve the predictive model for survival and toxicity in patients with cervical cancer through multicentric prospective data collection. The data contain information on patient, tumor and treatment characteristics. For this study, additional health related QOL scores will be assessed using the EORTC Quality of Life Questionair-CX24 and C30. The long term aim, beyond this specific study, is to build a Decision Support System based on the predictive model validated in this study.

Conditions

Timeline

Start date
2013-02-01
Primary completion
2018-08-01
Completion
2018-08-01
First posted
2013-04-05
Last updated
2019-05-10

Locations

2 sites across 2 countries: Netherlands, South Africa

Source: ClinicalTrials.gov record NCT01825005. Inclusion in this directory is not an endorsement.